HLB bioStepLtd Balance Sheet Health
Financial Health criteria checks 3/6
HLB bioStepLtd has a total shareholder equity of ₩103.6B and total debt of ₩59.8B, which brings its debt-to-equity ratio to 57.7%. Its total assets and total liabilities are ₩171.7B and ₩68.1B respectively.
Key information
57.7%
Debt to equity ratio
₩59.78b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩70.38b |
| Equity | ₩103.57b |
| Total liabilities | ₩68.14b |
| Total assets | ₩171.71b |
Recent financial health updates
Here's Why HLB bioStepLtd (KOSDAQ:278650) Has A Meaningful Debt Burden
Feb 28
Is KNOTUSLtd (KOSDAQ:278650) Using Too Much Debt?
Feb 03
Recent updates
Subdued Growth No Barrier To HLB bioStep Co.,Ltd. (KOSDAQ:278650) With Shares Advancing 29%
Mar 29Here's Why HLB bioStepLtd (KOSDAQ:278650) Has A Meaningful Debt Burden
Feb 28With EPS Growth And More, KNOTUSLtd (KOSDAQ:278650) Is Interesting
Mar 17What Kind Of Investors Own Most Of KNOTUS Co.,Ltd (KOSDAQ:278650)?
Feb 24Is KNOTUSLtd (KOSDAQ:278650) Using Too Much Debt?
Feb 03Investors Who Bought KNOTUSLtd (KOSDAQ:278650) Shares A Year Ago Are Now Up 26%
Jan 13Should We Be Delighted With KNOTUS Co.,Ltd's (KOSDAQ:278650) ROE Of 15%?
Dec 23Is Now The Time To Put KNOTUSLtd (KOSDAQ:278650) On Your Watchlist?
Dec 02Financial Position Analysis
Short Term Liabilities: A278650's short term assets (₩79.4B) exceed its short term liabilities (₩64.7B).
Long Term Liabilities: A278650's short term assets (₩79.4B) exceed its long term liabilities (₩3.5B).
Debt to Equity History and Analysis
Debt Level: A278650 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A278650's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A278650's debt is not well covered by operating cash flow (8.7%).
Interest Coverage: Insufficient data to determine if A278650's interest payments on its debt are well covered by EBIT.